We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$838B
AUM Growth
+$89B
Cap. Flow
+$31.1B
Cap. Flow %
3.71%
Top 10 Hldgs %
15.79%
Holding
6,872
New
693
Increased
2,351
Reduced
2,648
Closed
449
Avg Time Held Equity + Options
15 quarters
Top 10 Avg Time Held Equity + Options
12.5 quarters
Top 20 Avg Time Held Equity + Options
9.9 quarters
Avg Time Held Equity only
16.3 quarters
Top 10 Avg Time Held Equity only
12.8 quarters
Top 20 Avg Time Held Equity only
11.7 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.23%
2 Technology 15.68%
3 Financials 11.13%
4 Consumer Discretionary 9.78%
5 Healthcare 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DAO
3301
Youdao
DAO
$1.83B
$3.21M ﹤0.01%
138,783
+19,558
+16% +$473K
2019 Q4
6 quarters
PIPP
3302
DELISTED
Pine Island Acquisition Corp.
PIPP
$3.2M ﹤0.01%
328,786
+8,532
+3% +$84.4K
2021 Q1
1 quarter
KBAL
3303
DELISTED
Kimball International
KBAL
$3.2M ﹤0.01%
243,121
+23,137
+11% +$315K
2013 Q2
32 quarters
KOD icon
3304
Kodiak Sciences
KOD
$5.94B
$3.19M ﹤0.01%
34,334
+2,733
+9% +$262K
2018 Q4
10 quarters
RFP
3305
DELISTED
Resolute Forest Products Inc.
RFP
$3.19M ﹤0.01%
261,749
+214,569
+455% +$3.01M
2021 Q1
1 quarter
ONEM
3306
DELISTED
1Life Healthcare
ONEM
$3.19M ﹤0.01%
96,541
-826,991
-90% -$31.2M
2020 Q1
5 quarters
PAX icon
3307
Patria Investments
PAX
$1.65B
$3.18M ﹤0.01%
180,462
+170,170
+1,653% +$2.72M
2021 Q1
1 quarter
USDP
3308
DELISTED
USD PARTNERS LP
USDP
$3.18M ﹤0.01%
420,903
-9,561
-2% -$60.2K
2018 Q4
10 quarters
BHB icon
3309
Bar Harbor Bankshares
BHB
$661M
$3.18M ﹤0.01%
110,978
-31,081
-22% -$916K
2017 Q3
15 quarters
BZH icon
3310
Beazer Homes USA
BZH
$891M
$3.18M ﹤0.01%
164,694
-76,153
-32% -$1.67M
2015 Q4
22 quarters
TDUP icon
3311
ThredUp
TDUP
$285M
$3.17M ﹤0.01%
109,006
-211,205
-66% -$4.55M
2021 Q1
1 quarter
HARP
3312
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$3.17M ﹤0.01%
22,832
-1,177
-5% -$225K
2019 Q1
9 quarters
FIRY
3313
Firy Inc
FIRY
$207M
$3.15M ﹤0.01%
7,264
+6,239
+609% +$2.23M
2020 Q3
3 quarters
ABEO icon
3314
Abeona Therapeutics
ABEO
$288M
$3.15M ﹤0.01%
80,880
+4,338
+6% +$177K
2017 Q4
14 quarters
UVV icon
3315
Universal Corp
UVV
$1.05B
$3.15M ﹤0.01%
55,270
-4,856
-8% -$280K
2013 Q2
32 quarters
XTN icon
3316
State Street SPDR S&P Transportation ETF
XTN
$307M
$3.15M ﹤0.01%
37,067
+1,799
+5% +$160K
2017 Q1
17 quarters
SHAK icon
3317
Shake Shack
SHAK
$2.46B
$3.14M ﹤0.01%
29,340
-39,973
-58% -$4.03M
2015 Q3
23 quarters
EBND icon
3318
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.23B
$3.14M ﹤0.01%
118,685
-13,887
-10% -$369K
2020 Q3
3 quarters
AMT icon
3319
PUT
American Tower
AMT
$75.6B
$3.13M ﹤0.01%
+11,600
New +$2.96M
2021 Q2
0 quarters
WOLF icon
3320
CALL
Wolfspeed
WOLF
$1.87B
$3.13M ﹤0.01%
32,000
+6,900
+27% +$696K
2021 Q1
1 quarter
PSTX
3321
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$3.13M ﹤0.01%
312,694
+1,832
+0.6% +$16.4K
2020 Q3
3 quarters
STR
3322
DELISTED
Sitio Royalties
STR
$3.13M ﹤0.01%
153,843
-25,671
-14% -$493K
2019 Q1
9 quarters
BCRX icon
3323
BioCryst Pharmaceuticals
BCRX
$2.09B
$3.12M ﹤0.01%
197,486
+33,518
+20% +$455K
2017 Q4
14 quarters
CERT icon
3324
CALL
Certara
CERT
$1.43B
$3.12M ﹤0.01%
+110,100
New +$3.06M
2021 Q2
0 quarters
BHVN
3325
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.12M ﹤0.01%
+32,100
New +$2.61M
2021 Q2
0 quarters

Similar funds

JP Morgan Chase's Q2 2021 Portfolio in Review

As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

JP Morgan Chase deployed $31.1B of net new capital in Q2 2021, opening 693 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.

  • JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
  • JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
  • JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
  • JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
  • JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
  • JP Morgan Chase opened 693 new positions and closed 449 in Q2 2021.
  • JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.

Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.